Peptide Lens

Peptide Lens

The studies behind the peptides.

The Peptide Lens Ebook

26 compounds. What each one is, and what the studies found.

Our storeAscend VialsLab tested, 99%+ purity, ships from the US.Shop โ†’

Start here

Peptides are easy to get excited about and hard to get a straight answer on. So we read the studies and wrote them up the way a friend would explain them over coffee. Every compound gets a nickname, an everyday picture of how it works, the real science in plain words, and the proof: what the studies found, numbers and limits included. When the human data is thin, we say so.

  1. 1. Pick a goal below.
  2. 2. Tap it to open its compounds.
  3. 3. Questions? Ask in the Discord.

Pick a goal

Tap one to open it.

Fat Loss3 compounds ยท tap to open

Everyone knows the scale that will not budge and the fridge that starts calling at 10pm. Hunger is not a character flaw. It is hormones doing their job. These are the compounds scientists study to see what happens when those hunger signals get turned down.

Retatrutide

โ€œThe three-dial hunger signalโ€

Picture this: Imagine the body's hunger and fuel settings as dials on a mixing board. Most compounds in this family reach for one or two. This one reaches for three at once.

The science: A lab-made peptide from Eli Lilly that works on three receptors together: GIP, GLP-1 and glucagon. The glucagon part is meant to make the body burn more energy, but that has only been shown in mice.

The proof: In the best published study (338 adults, 48 weeks), the highest-amount group lost 24.2% of body weight on average, against 2.1% on placebo. About 1 in 6 people in that group quit because of how it made them feel. The famous 28% and 30% figures are company press releases, not published studies.

Why people look at it: it has the biggest published weight-loss number so far, though from a smaller, shorter study than its rivals.

Tirzepatide

โ€œThe two-dial hunger signalโ€

Picture this: Same mixing board, two dials. It is the middle sibling: semaglutide (Ozempic, Wegovy) turns one, retatrutide reaches for three, and this one sits in between.

The science: It works on two receptors at once, GIP and GLP-1. It is the compound in Mounjaro and Zepbound, made by the same company as retatrutide.

The proof: Its big published trial followed 2,539 people for 72 weeks and found 20.9% average weight loss. In the highest-amount group, 6% quit over side effects. The FDA approved it for weight loss as Zepbound in 2023. No head-to-head trial against retatrutide has been published.

Why people look at it: it is the approved one, with the largest and longest study of the three in its family.

5-Amino-1MQ

โ€œThe fat-cell gear jammerโ€

Picture this: Think of a fat cell as a tiny workshop where one gear helps decide what happens to energy. This is a wedge shaped to slip into that single gear.

The science: It is a small molecule that blocks NNMT, an enzyme fat cells use to manage energy.

The proof: This is the thin one, and we would rather say so than dress it up. No published study has given it to a person. The best-known result is in obese mice, 9 per group for 11 days: treated mice lost 5.1% of their weight while untreated mice gained 1.4%.

Why people look at it: it aims at how fat cells handle energy, a different target from the hunger-signal compounds above.

Healing & Recovery2 compounds ยท tap to open

The tendon that still twinges a year later. The gut that never quite settles. Repair is where peptides have their loudest reputation, and where the gap between rat results and human trials is widest. Here is what was actually measured.

Wolverine

BPC-157 + TB-500

โ€œThe two-person repair crewโ€

Picture this: A road crew at a pothole. One worker is known in the lab for calling in new supply lines, tiny blood vessels. The other is a copied piece of a natural protein tied to cells moving in to patch the gap.

The science: In dish studies, BPC-157 (15 amino acids) boosted VEGFR2, a blood-vessel receptor. TB-500 copies 7 amino acids from the actin-binding spot of thymosin beta-4. Neither mechanism is confirmed in a person.

The proof: In rats with a cut Achilles tendon, BPC-157 tendons took more force to break. A 2026 rat study found the same for TB-500 (37.4 vs 26.9 newtons, 4 rats per group), and adding BPC-157 added nothing. No full placebo-controlled human trial of BPC-157 has been published, and no study has given TB-500 to a person.

Why people look at it: the rat tendon results are striking, and the open question is whether they ever hold up in humans.

KLOW

BPC-157, TB-500, GHK-Cu, KPV

โ€œThe four-tool kitโ€

Picture this: A toolbox with four tools: two repair-research peptides, one copper carrier, and one tiny piece clipped from the end of a natural hormone. Each tool was tested on its own.

The science: BPC-157 and TB-500 are the pair from Wolverine. GHK-Cu is three amino acids gripping copper. KPV is the last three amino acids of the hormone alpha-MSH, and in cell studies it blocks NF-ฮบB, a switch for inflammation genes.

The proof: The parts were studied separately. In mice with an inflamed colon, KPV cut an inflammation marker by about 30% to 50% (5 to 10 mice per group). BPC-157 evidence is almost all rats and lab dishes, no study has given TB-500 or KPV to a person, and GHK-Cu has no controlled human trial as a shot.

Why people look at it: it bundles four of the most talked-about repair compounds, so it helps to see what each one really has behind it.

Growth Hormone6 compounds ยท tap to open

Growth hormone is behind a lot of gym talk and a lot of anti-aging talk. Most compounds here ask the pituitary gland to release more of its own, and one is the hormone itself. The question to hold onto in every study: did a higher blood level turn into anything a person could feel?

CP-10

Ipamorelin + CJC-1295

โ€œThe two-doorbell blendโ€

Picture this: The pituitary gland has more than one doorbell. This blend pairs a quick ring on one with a finger held down on the other, both asking for growth hormone.

The science: Ipamorelin switches on the ghrelin receptor, and half of it clears in about 2 hours. CJC-1295 copies part of GHRH, the brain's release signal, and its DAC hook latches onto a blood protein so it lingers for days.

The proof: On its own, CJC-1295 with DAC raised growth hormone 2 to 10 times for 6 days or more in healthy adults, and ipamorelin gave one spike that faded within hours. No published human study has tested the two together, and none measured muscle, fat or sleep.

Why people look at it: two signals adding up is an appealing idea, though the case for it comes from a 1990 study of a different peptide pairing.

Ipamorelin

โ€œThe quick GH doorbellโ€

Picture this: One press on a doorbell. A single ring, the gland answers with one burst of growth hormone, and then the hallway goes quiet again.

The science: A five-piece lab-made peptide from Novo Nordisk that switches on the ghrelin receptor, which makes the pituitary release growth hormone. That receptor also sits in the gut, heart and other organs.

The proof: In healthy men, a single drip into a vein gave one growth hormone spike that peaked at about 40 minutes, then faded. The only published patient trial (114 adults after bowel surgery) found no statistically significant benefit. No published human study tested it under the skin, or measured muscle, fat or sleep.

Why people look at it: it is called "selective", meaning it left stress hormones alone, but that was shown in pigs and never in a person.

Tesamorelin

โ€œThe full-length GHRH copyโ€

Picture this: The brain sends the pituitary a memo that says "release growth hormone". Tesamorelin is a photocopy of the whole memo with a protective cover stapled on, so it is harder to shred.

The science: It is the full 44-piece human GHRH plus a short fatty chain that makes it harder for a blood enzyme to break down. It contains no growth hormone. It tells the pituitary to release its own, which raises IGF-1.

The proof: It is FDA-approved as Egrifta for one use: extra belly fat in adults with HIV. Across two trials (806 people, 26 weeks), deep belly fat shrank about 15% more than on placebo. Weight barely moved, and the fat came back within about six months of stopping.

Why people look at it: it is one of the few compounds here with big placebo-controlled trials and an FDA approval behind it.

Sermorelin

โ€œThe short GHRH copyโ€

Picture this: If GHRH is a 44-word memo telling the pituitary to release growth hormone, sermorelin is the first 29 words. Enough for the gland to get the message.

The science: It copies the first 29 of GHRH's 44 amino acids. It is a signal, not a replacement: the pituitary releases the body's own growth hormone, which then pushes up IGF-1.

The proof: It was FDA-approved for children who lacked growth hormone until 2009, when the maker ended it for reasons other than safety. In older adults, trials of 5 to 6 months saw men's growth hormone double and IGF-1 rise about 40%, with fat and lean-mass results the authors called preliminary. Sleep ratings got slightly worse.

Why people look at it: it once held an FDA approval, so it has a longer paper trail than most peptides in this section.

HGH 191AA

โ€œThe growth signal itselfโ€

Picture this: The compounds above knock on the pituitary's door and ask. This one skips the door. It is the letter the gland would have sent, already written.

The science: Somatropin is a lab-made copy of the pituitary's own hormone: 191 amino acids in exactly the same order. It locks onto growth hormone receptors and switches on IGF-1.

The proof: A 2007 review of trials in healthy older adults (220 people on GH, about 27 weeks) found 2.1 kg more lean mass and 2.1 kg less fat, with weight unchanged and no clear gain in strength. Swelling, joint pain and carpal tunnel were common. The authors' verdict: not recommended as an anti-aging therapy.

Why people look at it: it is the original that the rest of this section tries to nudge, and it is FDA-approved for a short list of medical uses.

IGF-1 LR3

โ€œThe brake-dodging growth signalโ€

Picture this: The body keeps its IGF-1 growth signal on a leash: binding proteins that hold it back. LR3 is the same signal in a slippery collar, built to wriggle loose.

The science: A modified copy of IGF-1 with 13 extra amino acids and one swap. It uses the same IGF-1 receptor, but natural IGF-1 grips the body's binding proteins about 1,000 times more tightly than LR3 does.

The proof: No human study has ever been published. In rats it looked up to 6 times stronger than natural IGF-1, yet it left the blood about 11 times faster. The same animal studies found low blood sugar, and faster tumor growth in rats with breast tumors.

Why people look at it: it was built in 1992 as a lab research tool, and the animal data shows both why it drew attention and why it worries people.

Skin & Hair2 compounds ยท tap to open

A lot of peptide curiosity starts at the mirror: a new line here, a thinner patch there. Copper peptides show up on skincare labels, which makes them feel proven. The studies tell a more mixed story.

GHK-Cu

โ€œThe copper courierโ€

Picture this: A tiny courier with one parcel. The courier is three amino acids, the parcel is a single copper ion, and the delivery address is the cells that make collagen.

The science: GHK is a natural three-amino-acid peptide found in human blood in 1973. It grabs copper readily, and its discoverers proposed that its job is carrying copper into cells. In lab dishes, collagen-making cells made more collagen with it.

The proof: Nearly every human study put it on the skin. In 20 women over 8 weeks, wrinkle volume fell 24% on the GHK-Cu side against 15% on the plain side, in a study paid for by the serum's maker. As a wound gel, the biggest trial (511 people) failed. No controlled human trial has tested it as a shot.

Why people look at it: the body already makes it, and it has real, if modest, human skin data.

AHK-Cu

โ€œThe copper courier's cousinโ€

Picture this: The same idea as GHK-Cu with a slightly different courier: a three-link chain gripping one copper ion, said to make its deliveries to the cells around a hair follicle.

The science: It is a three-amino-acid peptide bound to copper, a close relative of GHK-Cu.

The proof: Thin, and we will say so plainly. We found one published study, from 2007: human hair follicles in a lab dish grew longer. We found no study of it in animals or in people.

Why people look at it: the interest is hair, and our guide found no controlled trial of GHK-Cu alone for hair loss either.

Energy & Longevity5 compounds ยท tap to open

Every cell runs on tiny power plants called mitochondria, and the pitch is simple: keep the power plants humming and the whole body feels younger. It is a great story. So far, most of it has been told in mice.

MOTS-C

โ€œThe mitochondria's own memoโ€

Picture this: Almost all of a cell's instruction manual sits in the nucleus. The power plants keep a few pages of their own, and MOTS-c is a short note written on those pages, thought to travel the body like a hormone.

The science: A 16-amino-acid peptide coded in mitochondrial DNA, first described in 2015. In cells it switched on AMPK, the cell's fuel gauge, though that explains only part of its effect. FDA reviewers say nobody knows what it latches onto in the body.

The proof: All in mice: after 2 weeks, old mice ran twice as long on a treadmill, and fat-fed mice gained less weight on the same calories. No study that gave MOTS-c to people has reported results. The "longer life" result was a 6.4% trend that was not statistically significant.

Why people look at it: the body makes it, and the mouse treadmill results are the kind that make headlines.

NAD+

โ€œThe cell's rechargeable shuttleโ€

Picture this: A rechargeable battery that every cell passes around, carrying energy between the steps that turn food into fuel. Cells build it from forms of vitamin B3.

The science: NAD+ is a helper molecule that many enzymes need, including ones tied to DNA repair. Older people tend to have less of it, but nobody has shown that the drop causes aging.

The proof: Almost every human trial tested NR or NMN pills, which the body turns into NAD+. In the biggest (140 adults, 8 weeks), blood NAD+ rose as much as 139%, yet the health results across trials were mixed and often zero. A 2026 review found no trials of NAD+ shots or drips for anti-aging or wellness.

Why people look at it: levels fall with age, and the open question is whether topping them up does anything. So far the blood number moves more than the health results do.

SS-31

โ€œThe power-plant wall huggerโ€

Picture this: A magnet to a fridge door. This tiny peptide is drawn to the inner wall of the mitochondria, the cell's power plants, and sticks there.

The science: Four amino acids, also known as elamipretide. Its FDA label says it sticks to cardiolipin, a fat in the mitochondria's inner wall. Nobody is sure exactly how it works.

The proof: The FDA approved it in September 2025 only for Barth syndrome, a rare disease with about 150 US patients, on a knee-strength test. In 39 healthy adults aged 60 to 85, one drip raised peak muscle energy 27% against 12% on placebo, and the gap was gone by day 7. Trials in heart failure and other diseases missed their main goals.

Why people look at it: it is a real approved drug aimed straight at mitochondria, and in mouse studies old mice ran longer on it.

Glutathione

โ€œThe cell's reusable spongeโ€

Picture this: A kitchen sponge that soaks up a spill, gets wrung out, and goes back to work. Glutathione does that inside cells with reactive molecules like hydrogen peroxide.

The science: A three-amino-acid peptide the body makes itself, with the most in the liver. One enzyme uses it to break down hydrogen peroxide and damaged fats, and a second enzyme recycles the spent form.

The proof: No trial has shown that raising it makes anyone healthier. In the only placebo-controlled drip study of skin lightening, 6 of 16 women got lighter against 3 of 16 on salt water, a gap that was not statistically significant. Eight women on glutathione were pulled from the study for abnormal liver tests.

Why people look at it: the body makes it, and it gets called the "master antioxidant", which our guide notes is a slogan and not a measurement.

Epithalon

โ€œThe four-link telomere questionโ€

Picture this: Chromosomes have protective caps on their ends, like the plastic tips on shoelaces. In lab dishes, this four-link chain switched on the enzyme that rebuilds those tips.

The science: Four amino acids (AEDG), modelled by a St. Petersburg group on a cattle pineal-gland extract. In cultured human cells it switched on telomerase, the enzyme that rebuilds telomeres.

The proof: Every telomere result comes from cells in a dish, including a 2025 independent study where telomerase activity rose 4-fold in normal connective-tissue cells. The only human study with a placebo spray had 40 women and ran 20 days. A melatonin marker rose 1.7-fold, and sleep was never measured.

Why people look at it: telomeres are one of the best-known aging markers, so a dish result draws attention. The FDA warns the same effect could also be a route to cancer.

Brain & Sleep4 compounds ยท tap to open

Three coffees deep and still foggy. Wired at midnight, wrecked at seven. This is the section everyone wants to work, which is exactly why it deserves the closest look: most of these studies are small, old, or published only in Russian.

Semax

โ€œThe clipped stress-hormone pieceโ€

Picture this: Take the stress hormone ACTH, snip out a four-letter word, and tape three new letters onto the end. According to its developers, the result has none of ACTH's hormone effects.

The science: Seven amino acids: four from ACTH plus Pro-Gly-Pro, designed in Moscow. The FDA says it works "through poorly understood mechanisms of action". The famous lead is BDNF, a protein that helps brain cells grow and connect.

The proof: In rats, BDNF in the brain's memory center rose up to 1.4-fold. In people, a pooled analysis of 3 stroke studies (181 patients) found better scores at 21 days, but the human studies are small, mostly in Russian, and none has been repeated by an independent group. In healthy adults, two brain-scan studies measured brain activity, not memory or focus.

Why people look at it: it is a registered medicine in Russia, and the rat BDNF result is the one everybody quotes.

Selank

โ€œTuftsin with a tailโ€

Picture this: Take a natural peptide called tuftsin and add a three-link tail, like a key with a longer handle. Which lock it turns is still unproven.

The science: Seven amino acids: tuftsin plus Pro-Gly-Pro, developed in Russia as nasal drops. Its label says it reaches the blood within 30 seconds and is broken down within about 5 minutes. How it works is unproven.

The proof: In the clearest trial (60 adults, 14 days), it cut anxiety scores 26% against 55% for a benzodiazepine, and nobody on Selank reported drowsiness. A week after stopping, 17 of 30 Selank patients counted as responders, against 9 of 30. No trial has tested it against a placebo.

Why people look at it: calm without drowsiness is a rare result, so the missing piece everyone wants is a placebo-controlled trial.

DSIP

โ€œThe nine-link sleep mysteryโ€

Picture this: A key named after the door it once opened in rabbits: deep-sleep brainwaves. In people, nobody has found the lock. No gene or receptor for it has turned up.

The science: DSIP is nine amino acids, found in 1977 when it boosted slow delta waves in rabbit brains. A 2006 review said no gene or receptor for it had been found, and in human blood half of it is reported gone in 7 to 8 minutes.

The proof: Every human sleep study had 18 people or fewer, all by drip into a vein, almost all from 1981 to 1998. One 14-person study saw sleep rise from 313 to 385 minutes a night, with no placebo group. The one trial with a separate placebo group (16 patients) called the effects weak.

Why people look at it: the name says deep sleep, and the question is whether the human data ever matched the name.

Pinealon

โ€œThe three-link brain puzzleโ€

Picture this: About as small as a peptide gets: three beads on a string. The name sounds like the pineal gland, but no study we found links it there.

The science: Three amino acids (EDR) from a St. Petersburg institute. The developers' ideas: it delays a stress signal called ERK1/2 in rat brain cells, and may act on DNA. None of it is confirmed in a person.

The proof: The human studies are small, written in Russian, and give no numbers that can be checked. The real numbers come from animals and dishes: in Alzheimer's-model mice (10 per group), the spines where nerve cells connect rose 11%, but a test of how well those connections strengthen did not improve.

Why people look at it: it comes from the same St. Petersburg group as Epithalon, and the question is whether the brain claims have numbers behind them.

Libido & Hormones2 compounds ยท tap to open

Desire is part brain, part hormones, and very hard to capture on a questionnaire. One compound here went all the way to FDA approval. The other is a hormone the body already makes. Both come with fine print worth reading.

PT-141

โ€œThe many-lock hormone copyโ€

Picture this: One key cut to fit a whole row of locks. Some of those locks sit on pigment cells in the skin, others on nerve cells in the brain and spinal cord.

The science: Bremelanotide is a seven-piece peptide modeled on the natural hormone alpha-MSH. It switches on a family of receptors, strongest at MC1R and then MC4R. Even its FDA label says how it raises desire is unknown.

The proof: The FDA approved it in 2019 as Vyleesi for one use: low sexual desire in women before menopause. In two trials (1,267 women, 24 weeks), desire rose about a third of a point more than placebo on a 1.2 to 6.0 scale, and satisfying sex did not become more frequent. 4 in 10 women got nausea.

Why people look at it: it is the one compound in this section that went through big FDA trials, so its numbers are the most solid.

Kisspeptin

โ€œThe first dominoโ€

Picture this: A row of dominoes. Kisspeptin tips the first one in the brain, and the fall runs all the way down to testosterone, estrogen and ovulation.

The science: A hormone the body already makes. It tells the brain to release GnRH, which tells the pituitary to release LH and FSH, which signal the testes or the ovaries.

The proof: In 6 healthy men, one drip lifted average LH to 10.8 against 4.2 on salt water, and testosterone ran about 15% higher for the next 3 hours. Given over and over for two weeks, the response shrank by about 90%. The studies are small, short and mostly from one London team.

Why people look at it: it sits at the very top of the hormone chain, and its strongest results so far are in IVF and hormone testing.

Tanning2 compounds ยท tap to open

A tan without the sun sounds like a cheat code. The body does have a real "make pigment" signal, and both compounds here copy it. One became an approved medicine for a rare disease. The other was tested for tanning in exactly three men.

Melanotan 1

โ€œThe pigment signal copyโ€

Picture this: The body has its own "make pigment" text message. Melanotan 1 is a sturdier copy of that text, read by the receptor on pigment cells.

The science: Also called afamelanotide, it copies the hormone alpha-MSH with 2 of its 13 amino acids swapped so it lasts longer. It locks onto MC1R on pigment cells, which then make more brown-black eumelanin, with or without sun.

The proof: As the implant SCENESSE it is approved for one rare light-sensitivity disease, not for tanning. In 7 volunteers, forearm eumelanin rose 98% in two weeks. The biggest tanning study had 77 people, and long-term skin cancer risk is unknown.

Why people look at it: it is the pigment peptide that became an approved medicine, and several of its small tanning studies had placebo groups.

Melanotan 2

โ€œThe master-key pigment signalโ€

Picture this: Where Melanotan 1 is known for one lock, this is a master key. It opens the pigment lock along with several others in the brain, gut and nerves.

The science: A ring-shaped, shortened copy of alpha-MSH from the University of Arizona. In lab tests it turns on at least four melanocortin receptors without favoring one, which fits what the trials saw: nausea, yawning and erections along with pigment.

The proof: The tan was tested in people once, on 3 men, and 2 of them got darker. It is not approved anywhere our guide checked, and the serious harms on record come from case reports, which cannot say how often they happen.

Why people look at it: it is the famous "tanning jab", and it is worth seeing how little human data sits under the reputation.

Join the Discord

Pick your topics and ask questions.

Where to get it

Ascend Vials is our own store: lab tested, 99%+ purity, ships from the US.

See Ascend Vials

Research only. Not medical advice.